TuHURA Biosciences
HURA
2 hedge funds and large institutions have $498K invested in TuHURA Biosciences in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
0.24% less ownership
Funds ownership: 1.71% → 1.48% (-0.24%)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $110K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Spark Investment Management
New York
|
-$107K |
| 2 |
D'Orazio & Associates
Falls Church,
Virginia
|
-$3K |
HURA Hedge Fund Activity: Q4 2016 in Review
2 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in TuHURA Biosciences (HURA) for Q4 2016, worth a combined $498K — down 53% from $1.07M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HURA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Spark Investment Management, exiting entirely with an estimated $107K sold.
- 2 institutional investors held TuHURA Biosciences (HURA) as of Q4 2016, down from 3 in Q3 2016.
- Funds reported $498K of TuHURA Biosciences stock for Q4 2016, down 53% quarter-over-quarter.
- 0 funds opened new TuHURA Biosciences positions in Q4 2016 and 1 closed out, a net change of -1 holder.
- The largest TuHURA Biosciences seller in Q4 2016 was Spark Investment Management, an estimated $107K sold.
Based on aggregated 13F filings for Q4 2016.